Search research articles
Contact Us
Filters
Showing results (351-360 of 374) with videos related to
Page
of 38
Sort By:
PLOS Global Public Health
|
April 14, 2023
METER (Mental health emergency response) program: Findings of psychological impact status and factors associated with depression, anxiety and stress among healthcare workers in public hospital in Malaysia during the COVID-19 pandemic
Nor Asiah Muhamad, Natasha Subhas, Normi Mustapha, et al.
JAMA Oncology
|
January 5, 2023
Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Correlative Analysis of the CALGB 40601 and PAMELA Trials
Aranzazu Fernandez-Martinez, Tomás Pascual, Baljit Singh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2015
Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib
Lisa A Carey, Donald A Berry, Constance T Cirrincione, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2011
Cancer and Leukemia Group B Pathology Committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues
David L Rimm, Torsten O Nielsen, Scott D Jewell, et al.
Nature Communications
|
November 4, 2023
Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials
Mattia Rediti, Aranzazu Fernandez-Martinez, David Venet, et al.
Diseases of the Colon and Rectum
|
June 15, 2026
Cost-Effectiveness of Pelvic Floor Reconstruction Using Biological Mesh After Extralevator Abdominoperineal resection for Rectal Cancer
Rudolf van den Berg, Gijsbert D Musters, Cornelis Verhoef, et al.
Seminars in Cancer Biology
|
October 13, 2017
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
Maria Vittoria Dieci, Nina Radosevic-Robin, Susan Fineberg, et al.
Indian Journal of Anaesthesia
|
July 5, 2022
Preoperative Investigations: Practice Guidelines from the Indian Society of Anaesthesiologists
Goneppanavar Umesh, S Bala Bhaskar, S S Harsoor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2012
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657
Laura J Esserman, Donald A Berry, Angela DeMichele, et al.
Annals of Surgery
|
October 22, 2016
Biological Mesh Closure of the Pelvic Floor After Extralevator Abdominoperineal Resection for Rectal Cancer: A Multicenter Randomized Controlled Trial (the BIOPEX-study)
Gijsbert D Musters, Charlotte E L Klaver, Robbert J I Bosker, et al.
Page
of 38
Search research articles
Search
Showing results (351-360 of 374) with videos related to
Sort By:
Page
of 38
PLOS Global Public Health
|
April 14, 2023
METER (Mental health emergency response) program: Findings of psychological impact status and factors associated with depression, anxiety and stress among healthcare workers in public hospital in Malaysia during the COVID-19 pandemic
Nor Asiah Muhamad, Natasha Subhas, Normi Mustapha, et al.
JAMA Oncology
|
January 5, 2023
Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Correlative Analysis of the CALGB 40601 and PAMELA Trials
Aranzazu Fernandez-Martinez, Tomás Pascual, Baljit Singh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2015
Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib
Lisa A Carey, Donald A Berry, Constance T Cirrincione, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2011
Cancer and Leukemia Group B Pathology Committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues
David L Rimm, Torsten O Nielsen, Scott D Jewell, et al.
Nature Communications
|
November 4, 2023
Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials
Mattia Rediti, Aranzazu Fernandez-Martinez, David Venet, et al.
Diseases of the Colon and Rectum
|
June 15, 2026
Cost-Effectiveness of Pelvic Floor Reconstruction Using Biological Mesh After Extralevator Abdominoperineal resection for Rectal Cancer
Rudolf van den Berg, Gijsbert D Musters, Cornelis Verhoef, et al.
Seminars in Cancer Biology
|
October 13, 2017
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
Maria Vittoria Dieci, Nina Radosevic-Robin, Susan Fineberg, et al.
Indian Journal of Anaesthesia
|
July 5, 2022
Preoperative Investigations: Practice Guidelines from the Indian Society of Anaesthesiologists
Goneppanavar Umesh, S Bala Bhaskar, S S Harsoor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2012
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657
Laura J Esserman, Donald A Berry, Angela DeMichele, et al.
Annals of Surgery
|
October 22, 2016
Biological Mesh Closure of the Pelvic Floor After Extralevator Abdominoperineal Resection for Rectal Cancer: A Multicenter Randomized Controlled Trial (the BIOPEX-study)
Gijsbert D Musters, Charlotte E L Klaver, Robbert J I Bosker, et al.
Page
of 38